Graft vs Host Disease: all 815 studies
Page 5 of 9. Open to participants first (138), then studies with results posted, then the rest; newest registration first within each.
- A Study to Investigate the Comparative Effectiveness of Ibrutinib in Steroid Dependent/Refractory cGVHD ParticipantsTerminatedNCT04852692
- Ruxolitinib With Calcineurin Inhibitor and Methotrexate vs. Calcineurin Inhibitor Plus Methotrexate and Mycophenolate Mofetil as Graft Versus Host Disease Prophylaxis for HLA-haploidentical Hematopoietic Stem Cell TransplantationCompletedNCT04838704Not applicable
- The Effects and Safety of 5% Lifitegrast Ophthalmic Solution in Subjects With Dry Eye Disease in Ocular Graft-versus-Host DiseaseCompletedNCT04792580Early Phase 1
- MaaT013 As Salvage Therapy in Ruxolitinib Refractory GI-aGVHD PatientsActive, not recruitingNCT04769895Phase 3
- Safety and Efficacy of Pro-ocular™ 1% in Daily Scleral Lens Wearing Patients With Ocular Graft-versus-Host DiseaseStatus unknownNCT04769648Phase 2/3
- The Influence of Extracorporeal Photopheresis on Skin SclerosisCompletedNCT04752397
- Efficacy and Safety of UC-MSCs for the Treatment of Steroid-resistant aGVHD Following Allo-HSCTCompletedNCT04738981Phase 3
- Evaluation of Dextenza in Patients With Ocular GVHD and Effects on Ocular Surface Disease OutcomesWithdrawnNCT04728646Phase 4
- Acalabrutinib in CLL and MCL Patients Subjected to Allogeneic Hematopoietic Stem Cell Transplantation (alloSCT)CompletedNCT04716075Phase 2
- Prospective Study of FMT for Acute Intestinal GVHD After Allo-HSCTStatus unknownNCT04711967Not applicable
- MSC for Treatment of cGVHD After Allo-HSCTStatus unknownNCT04692376Phase 2
- A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT.Status unknownNCT04688021Phase 2
- Feasibility and Efficacy of Modified Donor Lymphocytes Infusion (CD45RA Negative Selected) After Haploidentical Transplantation With Post-transplantation Cyclophosphamide in Patients With Hematological Malignancies (ONC-2016-002).CompletedNCT04687982Not applicable
- PTCy and Ruxolitinib vs PTCy, Tacrolimus and MMF in MUD and Haploidentical HSCTCompletedNCT04669210Phase 2
- Efficacy and Safety of FMT Capsule Treating Steroid-refractory GI-aGvHDStatus unknownNCT04622475Not applicable
- Cellular Stress Reactions During Graft-versus-host DiseaseCompletedNCT04558788
- Study to Evaluate the Safety and Pharmacokinetics of Efmarodocokin Alfa in Combination With Standard of Care in Participants Undergoing Allogeneic Hematopoietic Stem Cell TransplantationCompletedNCT04539470Phase 1
- Multidisciplinary Intervention In Chronic GVHDActive, not recruitingNCT04479995Not applicable
- Haplo Peripheral Blood Sct In GVHD PreventionCompletedNCT04473911Phase 1
- Sitagliptin for the Treatment of Grade 3-4 and Refractory Acute Graft-versus-host DiseaseStatus unknownNCT04448587Phase 2
- Matched Related and Unrelated Donor Stem Cell Transplantation for Severe Combined Immune Deficiency (SCID): Busulfan-based Conditioning With h-ATG, Radiation, and SirolimusWithdrawnNCT04370795Phase 1/2
- Identification of Novel Targetable Kinases in SR-a GvHDCompletedNCT04342442
- Interferon γ-Primed Mesenchymal Stromal Cells as Prophylaxis for Acute Graft v Host DiseaseTerminatedNCT04328714Phase 1
- Extracorporal Photopheresis With UVADEX Plus Standard Steroid Treatment for High Risk Acute Graft-versus-host DiseaseActive, not recruitingNCT04291261Phase 2
- Treatment of Patients With Teduglutide (GLP-2) for GVHD and Analysis of Paneth Cells of GVHD PatientsCompletedNCT04290429Early Phase 1
- FMT for Steroid Resistant Gut Acute GVHDStatus unknownNCT04285424Early Phase 1
- Fecal Microbiota Transplantation for the Treatment of Severe Acute Gut Graft-Versus-Host DiseaseWithdrawnNCT04280471Phase 1
- Anlotinib Treatment in Steroid Depenent/Refractory cGVHDTerminatedNCT04232397Phase 2
- The Skin Microbiome in Graft Versus Host DiseaseActive, not recruitingNCT04231500
- ALPN-101 in Steroid-resistant or Steroid-refractory Acute GVHDTerminatedNCT04227938Phase 1
- A Study of IBI377 in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host DiseaseTerminatedNCT04220632Phase 1/2
- Vigamox Treatment for Ocular Graft-Versus-Host DiseaseWithdrawnNCT04204122Phase 2
- ATG Plus PTCy vs ATG for CGVHD ProphylaxisActive, not recruitingNCT04202835Phase 2
- Efficacy and Safety of SCM-CGH in Patients With Steroid-Refractory or Dependent Chronic Graft-Versus-Host DiseaseActive, not recruitingNCT04189432Phase 2
- Neihulizumab for Standard-Risk Acute Graft Versus Host Disease (GVHD)CompletedNCT04144036Phase 1
- FMT In High-Risk Acute GVHD After ALLO HCTCompletedNCT04139577Phase 1
- Baricitinib for the Prophylaxis of Graft-Versus-Host Disease After Peripheral Blood Hematopoietic Cell TransplantationCompletedNCT04131738Phase 1
- Itacitinib for the Prevention of Graft Versus Host Disease in Patients Undergoing Donor Stem Cell TransplantationWithdrawnNCT04127721Phase 2
- Decidua Stroma Cells for Steroid Resistent Acute Graft-versus-host Disease After Allo-HSCTTerminatedNCT04118556Phase 2
- PT-CY With or Without Low-dose ATG for Lymphoid Malignancies Undergoing Allo-HSCTCompletedNCT04118075Phase 2
- Itacitinib and Tocilizumab for Steroid Refractory Acute Graft Versus Host DiseaseTerminatedNCT04070781Phase 1
- Fecal Microbiota Transplantation For The Treatment Of Gastro-Intestinal Acute GVHDWithdrawnNCT04059757Phase 2
- Pediatric cGVHD Symptom ScaleActive, not recruitingNCT04044365
- Origin of CEC in Patients After Allo-HSCTCompletedNCT04038827
- TCDαβ/CD45RA Haploidentical Transplantation in Children With LeukemiaStatus unknownNCT04033627Not applicable
- Heidelberg In Vivo Confocal Microscopy to Evaluate the Ocular Surface Disorders of Healthy and Diseased IndividualsStatus unknownNCT04025801
- ApoGraft for the Prevention of Acute Graft Versus Host Disease in Haploidentical Hematopoietic Cell Transplant RecipientsTerminatedNCT04006652Phase 1
- MPH966 for Prevention of Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell TransplantationWithdrawnNCT03986086Phase 1/2
- Optimizing PTCy Dose and TimingActive, not recruitingNCT03983850Phase 1/2
- Treosulfan-TMI Conditioning and Rapamycin GvHD Prophylaxis Before Allo-HSCTTerminatedNCT03963024Phase 1
- Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant TransplantActive, not recruitingNCT03924401Phase 2
- Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant CyclophosphamideActive, not recruitingNCT03910452Early Phase 1
- Clinical Evaluation of the Application of the FilmArray GI Panel in Post-HSCT Diarrhea PatientsStatus unknownNCT03894488
- Prevalence of Chronic Oral Graft Versus Host Disease Risk Factors in Pediatric PatientsStatus unknownNCT03880214
- Fecal Transplant +/- Gut Decontamination in Preventing Acute Graft Versus Host Disease in Patients Given Broad-Spectrum AntibioticsWithdrawnNCT03862079Phase 2
- Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow TransplantationActive, not recruitingNCT03842696Phase 1/2
- Minor Salivary Gland Transplantation for Cicatrizing ConjunctivitisStatus unknownNCT03839069Not applicable
- Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell TransplantationStatus unknownNCT03836690Phase 1
- Phase 1/2 Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects With Chronic Graft Versus Host Disease (cGVHD)CompletedNCT03790332Phase 1/2
- Prophylactic Donor Lymphocyte Infusion After Allo-PBSCT for Patients With Very High-risk Hematologic MalignanciesStatus unknownNCT03771222Phase 2
- Human Amniotic Epithelial Cells Prevent Acute Graft-versus-host Disease After Hematopoietic Stem Cell TransplantationStatus unknownNCT03764228Not applicable
- Diadenosine Polyphosphates and Mucin Associated With Ocular Surface DisordersStatus unknownNCT03731624
- Optimization of Antibiotic Treatment in Hematopoietic Stem Cell ReceptorsCompletedNCT03727113
- PTCy-ATG vs ATG in Haploidentical HSCT for Acute Graft-versus-host Disease ProphylaxisStatus unknownNCT03689465Phase 4
- Donor Regulatory T-cells for Steroid-Refractory Chronic Graft-versus-host-DiseaseCompletedNCT03683498Phase 1
- Expansion of Invariant NKT Cells for a Cell Immunotherapeutic Approach Allowing the Control of Graft Versus Host-disease and Preserving the Graft Versus Leukemia Effect After Allogeneic Hematopoietic Stem Cell TransplantationStatus unknownNCT03605953
- A Study Comparing Corticosteroids Alone Versus Corticosteroids and Extracorporal Photopheresis (ECP) as First-line Treatment of Standard II Acute Graft-versus-host DiseaseStatus unknownNCT03605940Phase 2
- CD40-L Blockade for Prevention of Acute Graft-Versus-Host DiseaseCompletedNCT03605927Phase 1
- Chronic Graft-versus-Host Disease in the Oral Cavity of Patients Following Allogeneic Hematopoietic Stem Cell Transplant and Including Healthy ControlsCompletedNCT03602599
- Haplocompatible Transplant Using TCRα/β Depletion Followed by CD45RA-Depleted Donor Lymphocyte Infusions for Severe Combined Immunodeficiency (SCID)Active, not recruitingNCT03597594Phase 1/2
- Characteristics and Dynamics of TCR Repertoire in Patients With Hematological Malignancies After Allo-HSCTCompletedNCT03575767
- Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel ImmunotherapiesTerminatedNCT03557749
- Fecal Microbiota Transplantation for Treatment of Refractory Graft Versus Host Disease-a Pilot StudyStatus unknownNCT03549676Phase 1
- 18-FLT PET/MR Imaging to Predict Graft Failure and GVHD in Bone Marrow Transplant PatientsTerminatedNCT03546556Early Phase 1
- Safety of Itacitinib in Combination With Corticosteroids for Treatment of Steroid-Naive Acute Graft-Versus-Host Disease in Japanese SubjectsCompletedNCT03497273Phase 1
- Autologous Fecal Microbiota Transplantation for Patients With Acute Graft-versus-Host DiseaseWithdrawnNCT03492502Not applicable
- HIgh Dose Thymoglobulin Instead of Cyclosporine With a Low Dose of Thymoglobulin for GVHD ProphylaxisTerminatedNCT03456817Phase 2
- Dynamic of Immunocompetent Populations in Patients Treated With Extracorporeal Photopheresis in Chronic Graft Versus Host DiseaseTerminatedNCT03438643
- Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Prophylaxis With PosaconazoleCompletedNCT03434704Phase 2
- Glasdegib in Refractory Patients With Sclerotic Chronic Graft-Versus-Host DiseaseStatus unknownNCT03415867Phase 1/2
- Low Dose ATG Plus Low Dose PTCy as GVHD Prophylaxis in Haplo-HSCTStatus unknownNCT03395860Phase 2
- To Compare the Efficacy of the Addition of Methotrexate (MTX) to Current Standard Acute Graft-versus-host Disease (GVHD) First-line Treatment With CorticosteroidsCompletedNCT03371667Phase 3
- Cryopreservation of White Blood Cells Before Their UVA Irradiation for Graft Versus Host Disease TreatmentStatus unknownNCT03361254Not applicable
- Mechanisms of Action of Photo(Chemo)Therapy in Skin DiseasesStatus unknownNCT03340155Not applicable
- Neihulizumab (ALTB-168) in Patients With Steroid-refractory Acute Graft-versus-host Disease or Treatment-refractory Acute Graft-versus-host DiseaseCompletedNCT03327857Phase 1
- GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host DiseaseTerminatedNCT03320642Phase 1
- The Safety and Tolerability of Pirfenidone for BOS After HCTCompletedNCT03315741Phase 1
- Chemotherapy and DLI for Prevention of Second Relapse in Patients With Relapsed Acute Leukemia After AllotransplantStatus unknownNCT03297528Phase 2
- Post Transplant Cyclophosphamide (PTCY) as Sole Graft Versus Host Disease (GVHD) Prophylaxis for Matched Allotransplant: CYRICTerminatedNCT03263767Phase 2
- Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.Active, not recruitingNCT03229200Phase 4
- Ixazomib in the Prophylaxis of Chronic Graft-versus-host Disease.Active, not recruitingNCT03225417Phase 1/2
- Fecal Microbiota Transplantation for Steroid Resistant and Steroid Dependent Gut Acute Graft Versus Host DiseaseStatus unknownNCT03214289Phase 1
- Prevention of GVHD in Patients Treated With Allogeneic SCT: Possible Role of Extracorporeal PhotophoresisCompletedNCT03204721Not applicable
- A Optimal Anti-Thymoglobuline (ATG) Dose Decrease cGVHD But Not Increase Leukemia Relapse for Haplo-HSCTStatus unknownNCT03190733Phase 4
- Early Access Program Using Alpha 1 Antitrypsin Infusion for Patients With Steroid Refractory Acute GvHD After Hematopoietic Stem Cell Transplantation (HSCT)No longer availableNCT03172455
- Changes in the Gut Microbiota of Patients Undergoing Allogeneic Stem Cell Transplantation (COLLECT)Status unknownNCT03148197
- An Expanded Access Program of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell TransplantApproved for marketingNCT03147742
- Analysis of Transcriptomic Profile of Graft-versus-host Disease (GHVD) After Allogeneic Grafting of Hematopoietic Stem CellsWithdrawnNCT03136757
- Clinical and Biomarker Study of the Efficacy of Extracorporeal Photopheresis in Graft-versus-host DiseaseCompletedNCT03124056
- Gluten Free Diet in Preventing Graft Versus Host Disease in Patients Undergoing Donor Stem Cell TransplantTerminatedNCT03102060Not applicable